Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Delayed peripheral treatment with neurotrophin-3 improves sensorimotor recovery after central nervous system injury.

Kakanos SG, Moon LDF.

Neural Regen Res. 2019 Oct;14(10):1703-1704. doi: 10.4103/1673-5374.257518. No abstract available.

2.

Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models.

Hutson TH, Kathe C, Palmisano I, Bartholdi K, Hervera A, De Virgiliis F, McLachlan E, Zhou L, Kong G, Barraud Q, Danzi MC, Medrano-Fernandez A, Lopez-Atalaya JP, Boutillier AL, Sinha SH, Singh AK, Chaturbedy P, Moon LDF, Kundu TK, Bixby JL, Lemmon VP, Barco A, Courtine G, Di Giovanni S.

Sci Transl Med. 2019 Apr 10;11(487). pii: eaaw2064. doi: 10.1126/scitranslmed.aaw2064.

PMID:
30971452
3.

Stroke Recovery in Rats after 24-Hour-Delayed Intramuscular Neurotrophin-3 Infusion.

Duricki DA, Drndarski S, Bernanos M, Wood T, Bosch K, Chen Q, Shine HD, Simmons C, Williams SCR, McMahon SB, Begley DJ, Cash D, Moon LDF.

Ann Neurol. 2019 Jan;85(1):32-46. doi: 10.1002/ana.25386. Epub 2018 Dec 28.

5.

Clarification of the basis for the selection of requirements for publication in the British Journal of Pharmacology.

Curtis MJ, Ashton JC, Moon LDF, Ahluwalia A.

Br J Pharmacol. 2018 Sep;175(18):3633-3635. doi: 10.1111/bph.14443. No abstract available.

PMID:
30144042
6.

An intriguing way to enhance rehabilitation of grasping in rats after spinal cord injury.

Spejo AB, Moon LDF.

Brain. 2018 Jul 1;141(7):1888-1899. doi: 10.1093/brain/awy148. No abstract available.

PMID:
30053175
7.

Chromatolysis: Do injured axons regenerate poorly when ribonucleases attack rough endoplasmic reticulum, ribosomes and RNA?

Moon LDF.

Dev Neurobiol. 2018 Oct;78(10):1011-1024. doi: 10.1002/dneu.22625. Epub 2018 Aug 1. Review.

8.

'Chase': in dogged pursuit of a therapy for spinal cord injury.

Moon LDF, Bradbury EJ.

Brain. 2018 Apr 1;141(4):941-943. doi: 10.1093/brain/awy067. No abstract available.

PMID:
29596667
9.

The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments).

Percie du Sert N, Alfieri A, Allan SM, Carswell HV, Deuchar GA, Farr TD, Flecknell P, Gallagher L, Gibson CL, Haley MJ, Macleod MR, McColl BW, McCabe C, Morancho A, Moon LD, O'Neill MJ, Pérez de Puig I, Planas A, Ragan CI, Rosell A, Roy LA, Ryder KO, Simats A, Sena ES, Sutherland BA, Tricklebank MD, Trueman RC, Whitfield L, Wong R, Macrae IM.

J Cereb Blood Flow Metab. 2017 Nov;37(11):3488-3517. doi: 10.1177/0271678X17709185. Epub 2017 Aug 11. Review.

10.

The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury.

Haenzi B, Moon LD.

Neural Plast. 2017;2017:2740768. doi: 10.1155/2017/2740768. Epub 2017 Jan 18. Review.

11.
12.

Analysis of longitudinal data from animals with missing values using SPSS.

Duricki DA, Soleman S, Moon LD.

Nat Protoc. 2016 Jun;11(6):1112-29. doi: 10.1038/nprot.2016.048. Epub 2016 May 19.

13.

The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity.

Harrison BJ, Venkat G, Lamb JL, Hutson TH, Drury C, Rau KK, Bunge MB, Mendell LM, Gage FH, Johnson RD, Hill CE, Rouchka EC, Moon LD, Petruska JC.

J Neurosci. 2016 Apr 13;36(15):4259-75. doi: 10.1523/JNEUROSCI.2423-15.2016.

14.

Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats.

Haenzi B, Gers-Barlag K, Akhoundzadeh H, Hutson TH, Menezes SC, Bunge MB, Moon LD.

PLoS One. 2016 Mar 25;11(3):e0150541. doi: 10.1371/journal.pone.0150541. eCollection 2016.

15.

Trans-neuronal transduction of spinal neurons following cortical injection and anterograde axonal transport of a bicistronic AAV1 vector.

Hutson TH, Kathe C, Moon LD.

Gene Ther. 2016 Feb;23(2):231-6. doi: 10.1038/gt.2015.103. Epub 2015 Dec 10.

16.

Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke.

Duricki DA, Hutson TH, Kathe C, Soleman S, Gonzalez-Carter D, Petruska JC, Shine HD, Chen Q, Wood TC, Bernanos M, Cash D, Williams SC, Gage FH, Moon LD.

Brain. 2016 Jan;139(Pt 1):259-75. doi: 10.1093/brain/awv341. Epub 2015 Nov 27.

17.

Experimental design and analysis and their reporting: new guidance for publication in BJP.

Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, Gilchrist A, Hoyer D, Insel PA, Izzo AA, Lawrence AJ, MacEwan DJ, Moon LD, Wonnacott S, Weston AH, McGrath JC.

Br J Pharmacol. 2015 Jul;172(14):3461-71. doi: 10.1111/bph.12856. No abstract available. Erratum in: Br J Pharmacol. 2015 Sep;172(18):4600.

18.

Unilateral pyramidotomy of the corticospinal tract in rats for assessment of neuroplasticity-inducing therapies.

Kathe C, Hutson TH, Chen Q, Shine HD, McMahon SB, Moon LD.

J Vis Exp. 2014 Dec 15;(94). doi: 10.3791/51843.

19.

The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system.

Hutson TH, Kathe C, Menezes SC, Rooney MC, Bueler H, Moon LD.

Methods Mol Biol. 2014;1162:189-207. doi: 10.1007/978-1-4939-0777-9_16.

20.

categoryCompare, an analytical tool based on feature annotations.

Flight RM, Harrison BJ, Mohammad F, Bunge MB, Moon LD, Petruska JC, Rouchka EC.

Front Genet. 2014 Apr 29;5:98. doi: 10.3389/fgene.2014.00098. eCollection 2014.

21.

Lentiviral vector-mediated RNA silencing in the central nervous system.

Hutson TH, Foster E, Moon LD, Yáñez-Muñoz RJ.

Hum Gene Ther Methods. 2014 Feb;25(1):14-32. doi: 10.1089/hgtb.2013.016. Epub 2013 Nov 1. Review.

22.

Therapeutics targeting Nogo-A hold promise for stroke restoration.

Kumar P, Moon LD.

CNS Neurol Disord Drug Targets. 2013 Mar;12(2):200-8. Review.

23.

Lentiviral vectors encoding short hairpin RNAs efficiently transduce and knockdown LINGO-1 but induce an interferon response and cytotoxicity in central nervous system neurones.

Hutson TH, Foster E, Dawes JM, Hindges R, Yáñez-Muñoz RJ, Moon LD.

J Gene Med. 2012 May;14(5):299-315. doi: 10.1002/jgm.2626.

24.

Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats.

Soleman S, Yip PK, Duricki DA, Moon LD.

Brain. 2012 Apr;135(Pt 4):1210-23. doi: 10.1093/brain/aws027. Epub 2012 Mar 6.

25.

Optimization of a 96-Well Electroporation Assay for Postnatal Rat CNS Neurons Suitable for Cost-Effective Medium-Throughput Screening of Genes that Promote Neurite Outgrowth.

Hutson TH, Buchser WJ, Bixby JL, Lemmon VP, Moon LD.

Front Mol Neurosci. 2011 Dec 23;4:55. doi: 10.3389/fnmol.2011.00055. eCollection 2011.

26.

Will stem cell therapies be safe and effective for treating spinal cord injuries?

Thomas KE, Moon LD.

Br Med Bull. 2011;98:127-42. doi: 10.1093/bmb/ldr013. Epub 2011 May 17. Review.

27.

Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.

Hutson TH, Verhaagen J, Yáñez-Muñoz RJ, Moon LD.

Gene Ther. 2012 Jan;19(1):49-60. doi: 10.1038/gt.2011.71. Epub 2011 May 12.

28.

CCL2 is a key mediator of microglia activation in neuropathic pain states.

Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, McMahon SB.

Eur J Pain. 2009 Mar;13(3):263-72. doi: 10.1016/j.ejpain.2008.04.017. Epub 2008 Jun 12.

PMID:
18554968
30.

Motor enrichment sustains hindlimb movement recovered after spinal cord injury and glial transplantation.

Moon LD, Leasure JL, Gage FH, Bunge MB.

Restor Neurol Neurosci. 2006;24(3):147-61.

PMID:
16873970
31.

Therapeutic interventions after spinal cord injury.

Thuret S, Moon LD, Gage FH.

Nat Rev Neurosci. 2006 Aug;7(8):628-43. Review. Erratum in: Nat Rev Neurosci. 2006 Nov;7(11):902.

PMID:
16858391
32.
34.

Schwann cells for spinal cord repair.

Oudega M, Moon LD, de Almeida Leme RJ.

Braz J Med Biol Res. 2005 Jun;38(6):825-35. Epub 2005 Jun 1. Review.

35.

Non-Hodgkin's lymphoma presenting with uterine and renal enlargement in a young girl.

Moon LD, Brenner C, Ancliff P, McHugh K, DeBruyn R.

Pediatr Radiol. 2004 Mar;34(3):277-9. Epub 2003 Nov 4.

PMID:
14600795
36.
37.

Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.

Moon LD, Asher RA, Fawcett JW.

J Neurosci Res. 2003 Jan 1;71(1):23-37.

PMID:
12478611
38.

Chondroitinase ABC promotes functional recovery after spinal cord injury.

Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB.

Nature. 2002 Apr 11;416(6881):636-40.

PMID:
11948352
40.
41.

Chondroitin sulphate proteoglycans: inhibitory components of the glial scar.

Asher RA, Morgenstern DA, Moon LD, Fawcett JW.

Prog Brain Res. 2001;132:611-9. Review. No abstract available.

PMID:
11545024
42.

Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC.

Moon LD, Asher RA, Rhodes KE, Fawcett JW.

Nat Neurosci. 2001 May;4(5):465-6. No abstract available.

PMID:
11319553
43.

Robust regeneration of CNS axons through a track depleted of CNS glia.

Moon LD, Brecknell JE, Franklin RJ, Dunnett SB, Fawcett JW.

Exp Neurol. 2000 Jan;161(1):49-66.

PMID:
10683273

Supplemental Content

Support Center